Overview

Erector Spinae Block With Ropivacaine and Dexmedetomidine on Opioid Consumption After Lumar Spine Surgeries

Status:
Not yet recruiting

Trial end date:
2023-05-30

Target enrollment:

Participant gender:

Summary

The aim of this study is to investigate the role of 0.5 micrograms/kg of dexmedetomidine with 0.2 % ropivacaine in erector spinae block in reducing opioid consumption for patients undergoing lumbar spine surgeries. This study will help in understanding the role of adding dexmdetomidine to ropivacaine in erector spinae block in reducing opioid consumption after lumbar spine surgeries

Phase:

Phase 4

Details

Lead Sponsor:

Security Forces Hospital

Treatments:

Dexmedetomidine
Ropivacaine